Today we are talking with Dr. Lincoln Pasquina, Director of Clinical Development at Foundation Medicine. Dr. Pasquina leads a team that is on the cutting edge of the newest advances in comprehensive genomic profiling. These genomic tests help providers with therapy selection for their patients, expand the number of people who can enroll in trials, increase access to therapies for patients, and accelerate new drug development. Right now, his focus is on liquid biopsy and Foundation Medicine's new ctDNA tumor fraction algorithm that improves confidence in the test, especially when supporting next step decision making concerning negative results.
続きを読む
一部表示